AstraZeneca, Russia to launch joint trial of COVID-19 vaccines before end of year


AstraZeneca said Dec. 11 that it will begin a clinical trial of its COVID-19 vaccine in combination with Russia's COVID-19 vaccine before the end of the year. 

The trial will enroll volunteers 18 years and older. 

Preliminary results have shown Russia's Sputnik V vaccine to be 90 percent effective in preventing COVID-19 infection, according to The Hill. Russia authorized the vaccine in August, the first country to do so. It began vaccinating people this week. 

Read AstraZeneca's full news release here


Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars